InvestorsHub Logo

Sukyamadda

05/21/23 2:23 PM

#17415 RE: theswordman #17414

At this point Lympro and Videssa are better options. Covid and long vivid is slowly leaving the media landscape. How many bottles of Tollovid have sold? After the only testing contract fails where is the revenue?